| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
Articles |
Department of Diagnostic Radiology, University Hospital Leiden, the Netherlands.
The potential of gadolinium (Gd)-DTPA to improve the detection of acute myocardial infarction by MR has been shown in experimental canine studies. To determine its value in humans, we studied five patients 2-17 days after myocardial infarction by using ECG-gated MR before and after administration of 0.1 mmol/kg Gd-DTPA. One patient had a rupture of the interventricular septum, complicating an acute inferior-wall infarction. Spin-echo images were obtained before and immediately after injection of Gd-DTPA and were repeated every 10 min for up to 40 min. In four patients, intensity-vs-time curves revealed increasing signal intensity in the infarcted area in the first 20 min after injection of gadolinium. Contrast between normal and infarcted myocardium was greatest 20-30 min after Gd-DTPA injection. In one patient, increasing signal intensity of the infarcted myocardium was observed up to 40 min after Gd-DTPA injection. The precontrast intensity ratio between infarcted and normal myocardium was 1.1 at echo time (TE) = 30 msec and was 1.4 at TE = 60 msec (p less than .05). The postcontrast intensity ratio was 1.6, which was not statistically different from the ratio at TE = 60 msec but which was significantly higher than the ratio at TE = 30 msec (p less than .01). Infarct definition was substantially improved on postcontrast images. The septal rupture was clearly seen, and the infarcted myocardium surrounding the septal rupture showed enhancement on postcontrast images. These results suggest that Gd-DTPA can improve MR visualization and detection of acute myocardial infarction.
CiteULike 
Complore 
Connotea 
Del.icio.us 
Digg 
Reddit 
Technorati What's this?
This article has been cited by other articles:
|
|
 |
|
  H. Thiele, M. J.E. Kappl, S. Conradi, J. Niebauer, R. Hambrecht, and G. Schuler Reproducibility of Chronic and Acute Infarct Size Measurement by Delayed Enhancement-Magnetic Resonance Imaging J. Am. Coll. Cardiol., April 18, 2006; 47(8): 1641 - 1645. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G B Bleeker, P Steendijk, E R Holman, C-M Yu, O A Breithardt, T A M Kaandorp, M J Schalij, E E van der Wall, P Nihoyannopoulos, and J J Bax Assessing right ventricular function: the role of echocardiography and complementary technologies Heart, April 1, 2006; 92(suppl_1): i19 - i26. [Full Text] [PDF]
|
|
|
|
|
|
R. J. Gibbons, U. S. Valeti, P. A. Araoz, and A. S. Jaffe The quantification of infarct size J. Am. Coll. Cardiol., October 19, 2004; 44(8): 1533 - 1542. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. Muthupillai, S. D. Flamm, J. M. Wilson, R. I. Pettigrew, and W. T. Dixon Acute Myocardial Infarction: Tissue Characterization with T1{rho}-weighted MR Imaging--Initial Experience Radiology, August 1, 2004; 232(2): 606 - 610. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. Mahrholdt, A. Wagner, R.M. Judd, and U. Sechtem Assessment of myocardial viability by cardiovascular magnetic resonance imaging Eur. Heart J., April 2, 2002; 23(8): 602 - 619. [Full Text] [PDF]
|
|
|
|
 |
|
 W. G. Rehwald, D. S. Fieno, E.-L. Chen, R. J. Kim, and R. M. Judd Myocardial Magnetic Resonance Imaging Contrast Agent Concentrations After Reversible and Irreversible Ischemic Injury Circulation, January 15, 2002; 105(2): 224 - 229. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
O. P. Simonetti, R. J. Kim, D. S. Fieno, H. B. Hillenbrand, E. Wu, J. M. Bundy, J. P. Finn, and R. M. Judd An Improved MR Imaging Technique for the Visualization of Myocardial Infarction Radiology, January 1, 2001; 218(1): 215 - 223. [Abstract] [Full Text]
|
|
|
|
|
|
K. Lauerma, P. Niemi, H. Hänninen, T. Janatuinen, L.-M. Voipio-Pulkki, J. Knuuti, L. Toivonen, T. Mäkelä, M. A. Mäkijärvi, and H. J. Aronen Multimodality MR Imaging Assessment of Myocardial Viability: Combination of First-Pass and Late Contrast Enhancement to Wall Motion Dynamics and Comparison with FDG PET-Initial Experience Radiology, December 1, 2000; 217(3): 729 - 736. [Abstract] [Full Text]
|
|
|
|
 |
|
 J. J. W. Sandstede, C. Lipke, M. Beer, K. Harre, T. Pabst, W. Kenn, S. Neubauer, and D. Hahn Analysis of First-Pass and Delayed Contrast-Enhancement Patterns of Dysfunctional Myocardium on MR Imaging: Use in the Prediction of Myocardial Viability Am. J. Roentgenol., June 1, 2000; 174(6): 1737 - 1740. [Abstract] [Full Text]
|
|
|
|
|
|
M. G. Friedrich, O. Strohm, J. Schulz-Menger, H. Marciniak, F. C. Luft, and R. Dietz Contrast Media–Enhanced Magnetic Resonance Imaging Visualizes Myocardial Changes in the Course of Viral Myocarditis Circulation, May 19, 1998; 97(18): 1802 - 1809. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. Matsuoka, M. Hamada, T. Honda, H. Kawakami, M. Abe, Y. Shigematsu, T. Sumimoto, and K. Hiwada Morphologic and Histologic Characterization of Cardiac Myxomas by Magnetic Resonance Imaging Angiology, July 1, 1996; 47(7): 693 - 698. [Abstract] [PDF]
|
|
|
|
|
|
E. E. van der Wall, H. W. Vliegen, A. de Roos, and A. V.G. Bruschke Magnetic Resonance Imaging in Coronary Artery Disease Circulation, November 1, 1995; 92(9): 2723 - 2739. [Abstract] [Full Text]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
